BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6994085)

  • 1. Plasma-protein binding of tricyclic antidepressants.
    Braithwaite RA
    Postgrad Med J; 1980; 56 Suppl 1():107-11. PubMed ID: 6994085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of tricyclic antidepressants and clinical efficacy: review of the literature -- part II.
    Risch SC; Huey LY; Janowsky DS
    J Clin Psychiatry; 1979 Feb; 40(2):58-69. PubMed ID: 581671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma level monitoring of tricyclic antidepressants: methodological and pharmacokinetic considerations.
    Gram LF
    Commun Psychopharmacol; 1978; 2(5):373-80. PubMed ID: 738017
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of various drugs on the binding of tianeptine to human plasma proteins.
    Zini R; Morin D; Salvadori C; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1991 Feb; 29(2):64-6. PubMed ID: 2026465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some factors affecting the plasma levels of tricyclic antidepressants.
    Moyes IC; Moyes RB
    Postgrad Med J; 1980; 56 Suppl 1():103-6. PubMed ID: 7393818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentrations of tricyclic antidepressants in clinical practice.
    Hollister LE
    J Clin Psychiatry; 1982 Feb; 43(2):66-9. PubMed ID: 7056706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Grapefruit juice as a contraindication? An approach in psychiatry].
    Vandel P; Regina W; Reix I; Vandel S; Sechter D; Bizouard P
    Encephale; 1999; 25(1):67-71. PubMed ID: 10205736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug level monitoring in psychopharmacology: usefulness and clinical problems, with special reference to tricyclic antidepressants.
    Gram LF; Pedersen OL; Kristensen CB; Bjerre M; Kragh-Sørensen P
    Ther Drug Monit; 1982; 4(1):17-25. PubMed ID: 7041335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H-Imipramine binding to human platelets. A peripheral index in depressive syndromes (author's transl)].
    Zarifian E; Sechter D; Bouchami F; Cuche H; Olie JP; Susini JR; Loo H; Briley M; Raisman R; Langer SZ
    Nouv Presse Med; 1982 Apr; 11(18):1385-7. PubMed ID: 7079155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].
    Ballon N; Siobud-Dorocant E; Even C; Slama F; Dardennes R
    Encephale; 2001; 27(4):373-6. PubMed ID: 11686060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clomipramine and desmethylclomipramine: relationship between plasma levels and clinical effect (author's transl)].
    Vandel B; Vandel S; Jounet JM; Allers G; Volmat R
    Encephale; 1981; 7(5):601-8. PubMed ID: 7327152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitive and rapid method for the simultaneous quantification of five antidepressants with their respective metabolites in plasma using high-performance liquid chromatography with diode-array detection.
    Aymard G; Livi P; Pham YT; Diquet B
    J Chromatogr B Biomed Sci Appl; 1997 Oct; 700(1-2):183-9. PubMed ID: 9390728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tricyclic antidepressants inhibit the Ca(2+)-dependent ATPase activity from plasma membrane.
    Plenge-Tellechea F; Soler F; Fernandez-Belda F
    Arch Biochem Biophys; 1999 Oct; 370(1):119-25. PubMed ID: 10496985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary observations of the significance of monitoring tricyclic antidepressant plasma levels in the pediatric patient.
    Dugas M; Zarifian E; Leheuzey MF; Rovei V; Durand G; Morselli PL
    Ther Drug Monit; 1980; 2(4):307-14. PubMed ID: 7222184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of cancer on the serum protein binding to mianserin and imipramine.
    Torres I; Suárez E; Rodríguez-Sasiain JM; Aguirre C; Calvo R
    Eur J Drug Metab Pharmacokinet; 1995; 20(2):107-11. PubMed ID: 8582434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha 1-acid glycoprotein involvement in high affinity binding of tricyclic antidepressants to human plasma.
    Javaid JI; Hendricks K; Davis JM
    Biochem Pharmacol; 1983 Apr; 32(7):1149-53. PubMed ID: 6847707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for clinical use in interpreting tricyclic plasma levels.
    Molnar G; Wallace J; Gupta R
    Can J Psychiatry; 1979 Oct; 24(6):532-6. PubMed ID: 487346
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacokinetics and plasma concentration of polycyclic antidepressants. General review of the product].
    Boyer P; Tsamis M; Mahuzier P
    Encephale; 1980; 6(4):333-47. PubMed ID: 6108206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring tricyclic antidepressant plasma levels.
    Sato TL; Madakasira S
    Am Fam Physician; 1984 May; 29(5):199-202. PubMed ID: 6731239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of free fractions of tricyclic antidepressants.
    Nyberg G; Mårtensson E
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(3):260-5. PubMed ID: 6493364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.